ALI MEA60: A porous thin-film microelectrode array for air-liquid interface electrophysiology of 3D excitable tissues

Objective: Conventional microelectrode arrays (MEAs) are suboptimal for long-term electrophysiology of three-dimensional (3D) excitable tissues, as limited oxygenation, nutrient diffusion, and tissue-electrode coupling compromise recording stability. Air-liquid interface (ALI) culture mitigates these constraints, but existing ALI MEA platforms are limited in channel count, flexibility, and compatibility with commercial multichannel acquisition systems. We developed and comprehensively characterized a next-generation ALI MEA for standardized, long-term recordings across multiple 3D excitable tissue models. Approach: The novel ALI MEA60 is composed of a porous polyimide membrane that integrates an array of 60 thin film microelectrodes (59 recording, one reference) and a basal perfusion chamber with Luer-lock connectors for controlled medium exchange and pharmacological wash-in/wash-out. It is compatible with the MEA2100-Mini data acquisition system (Multi Channel Systems). We characterized electrode impedance and noise across 41 ALI MEA60 devices, assessed 60-day stability with human iPSC-derived neural spheroids (N = 7 MEAs, 121 recordings) using a standardized longitudinal framework and linear mixed-effects models, and evaluated its versatility through pharmacological assays and recordings from human neural spheroids, brain organoids, ex vivo brain slices, and cardiac organoids. Main results: The platform showed reproducible electrical performance (median impedance 56 kOhms; at 1 kHz) and low noise (approx. 5uV Root Mean Square (RMS) in saline, 10-20 uV in medium), resolving spikes and local field potentials simultaneously. Recording remained stable for at least 60 days, with a stable noise floor and ~85% persistence of initial functional channels. Neural spheroids reproduced the standard qualitative signatures to gabazine, 4-aminopyridine (4-AP), and 6-Cyano-7-nitroquinoxaline-2,3-dione/D-2-amino-5-phosphonovalerate (CNQX/D-AP5), while cardiac organoids showed the expected beta-adrenergic response to isoproterenol. The ALI MEA60 can similarly record signals from human brain slices and organoids without hardware modification. Significance: The ALI MEA60 combines ALI culture, chronic recording stability, standardized pharmacological testing and cross-tissue compatibility in a single ready-to-use platform. It also establishes a reproducible framework for benchmarking long-term electrophysiological performance, thereby supporting disease modelling, drug discovery, organ-on-chip technologies and future chronic 3D electrophysiology systems. Keywords: microelectrode array (MEA); air-liquid interface (ALI); 3D excitable tissues; neural spheroids; cardiac organoids; chronic electrophysiology.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.16.766976
Primary Topic
Neuroscience and Neural Engineering
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

ALI MEA60: A porous thin-film microelectrode array for air-liquid interface electrophysiology of 3D excitable tissues

Jannis Meents, Michèle Giugliano, Alessio Di Clemente, Laetitia Nikles et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Neuroscience and Neural Engineering
preprint

ALI MEA60: A porous thin-film microelectrode array for air-liquid interface electrophysiology of 3D excitable tissues

Jannis Meents, Michèle Giugliano, Alessio Di Clemente, Laetitia Nikles, Théo Ribierre, Adam Armada‐Moreira, Laura Monni, Marc Olivier Heuschkel, Adrien Roux, Fabien Friscourt, S. Sivakumar, Julio Alvarez‐Collazo, Sven Schoenecker, MARISA JACONI, Michel Puceat, Luc Stoppini, Leonardo Scapozza, Thi-Thom Nguyen
preprint en

Abstract

Objective: Conventional microelectrode arrays (MEAs) are suboptimal for long-term electrophysiology of three-dimensional (3D) excitable tissues, as limited oxygenation, nutrient diffusion, and tissue-electrode coupling compromise recording stability. Air-liquid interface (ALI) culture mitigates these constraints, but existing ALI MEA platforms are limited in channel count, flexibility, and compatibility with commercial multichannel acquisition systems. We developed and comprehensively characterized a next-generation ALI MEA for standardized, long-term recordings across multiple 3D excitable tissue models. Approach: The novel ALI MEA60 is composed of a porous polyimide membrane that integrates an array of 60 thin film microelectrodes (59 recording, one reference) and a basal perfusion chamber with Luer-lock connectors for controlled medium exchange and pharmacological wash-in/wash-out. It is compatible with the MEA2100-Mini data acquisition system (Multi Channel Systems). We characterized electrode impedance and noise across 41 ALI MEA60 devices, assessed 60-day stability with human iPSC-derived neural spheroids (N = 7 MEAs, 121 recordings) using a standardized longitudinal framework and linear mixed-effects models, and evaluated its versatility through pharmacological assays and recordings from human neural spheroids, brain organoids, ex vivo brain slices, and cardiac organoids. Main results: The platform showed reproducible electrical performance (median impedance 56 kOhms; at 1 kHz) and low noise (approx. 5uV Root Mean Square (RMS) in saline, 10-20 uV in medium), resolving spikes and local field potentials simultaneously. Recording remained stable for at least 60 days, with a stable noise floor and ~85% persistence of initial functional channels. Neural spheroids reproduced the standard qualitative signatures to gabazine, 4-aminopyridine (4-AP), and 6-Cyano-7-nitroquinoxaline-2,3-dione/D-2-amino-5-phosphonovalerate (CNQX/D-AP5), while cardiac organoids showed the expected beta-adrenergic response to isoproterenol. The ALI MEA60 can similarly record signals from human brain slices and organoids without hardware modification. Significance: The ALI MEA60 combines ALI culture, chronic recording stability, standardized pharmacological testing and cross-tissue compatibility in a single ready-to-use platform. It also establishes a reproducible framework for benchmarking long-term electrophysiological performance, thereby supporting disease modelling, drug discovery, organ-on-chip technologies and future chronic 3D electrophysiology systems. Keywords: microelectrode array (MEA); air-liquid interface (ALI); 3D excitable tissues; neural spheroids; cardiac organoids; chronic electrophysiology.

bioRxiv (Cold Spring Harbor Laboratory)
University of Geneva (CH), University of Modena and Reggio Emilia (IT), Inserm (FR), HES-SO University of Applied Sciences and Arts Western Switzerland (CH), Aix-Marseille Université (FR), HES-SO Genève (CH), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR), University Hospital of Geneva (CH), Harvard Bioscience (Germany) (DE), Geneva College (US)
National Science Foundation, Haute école Spécialisée de Suisse Occidentale, Army Research Office, HORIZON EUROPE European Innovation Council
Good health and well-being
Neuroscience and Neural Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon